+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Anesthesia and Respiratory Devices Market Forecast to 2033- Product Image
Anesthesia and Respiratory Devices Market Forecast to 2033- Product Image
New

Anesthesia and Respiratory Devices Market Forecast to 2033

  • PDF Icon

    Report

  • 250 Pages
  • October 2025
  • Region: Global
  • Grand View Research
  • ID: 6189372
REQUEST CUSTOMIZATION
Description Jump to:
The global anesthesia and respiratory devices market size was estimated at USD 56.3 billion in 2024 and is expected to reach USD 91.5 billion by 2033, growing at a CAGR of 5.6% from 2025 to 2033. The industry is driven by an increased incidence of respiratory disorders such as Obstructive Sleep Apnea (OSA) and Chronic Obstructive Pulmonary Disease (COPD), fast urbanization, an increase in surgical operations, pollution levels, a geriatric population, and a smoking population.

For instance, according to the Australian Institute of Health and Welfare, in 2023, COPD accounted for 50% of the total burden of disease due to respiratory conditions and 3.6% of the total disease burden. Furthermore, according to the American Lung Association, in 2022, 4.6% of adults, or 11.7 million people, reported a diagnosis of chronic bronchitis, COPD, or emphysema.

The rising population of smokers is also leading to the increasing incidence of respiratory diseases, such as emphysema, bronchitis, cancer, and other lung diseases, which is leading to the growing demand for respiratory devices, hence boosting the market growth. According to WHO data published in July 2023, tobacco use is responsible for over 8 million deaths annually worldwide. Of these, more than 7 million are attributed to direct tobacco consumption, while approximately 1.3 million are due to second-hand smoke exposure among non-smokers.

Global Anesthesia And Respiratory Devices Market Report Segmentation

This report forecasts revenue growth at the global, regional and country levels and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the global anesthesia and respiratory devices market report based on product and region:

Product Mode Outlook (Revenue, USD Million, 2021-2033)

  • Respiratory Devices
  • Anesthesia Devices

Regional Outlook (Revenue, USD Million, 2021-2033)

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa

Why You Should Buy This Report

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

Report Deliverables

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Research Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product outlook
1.1.2. Regional scope
1.1.3. Estimates and forecast timeline.
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database.
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.2. Approach 1: Commodity flow approach
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Regional outlook
2.3. Competitive Insights
Chapter 3. Anesthesia and Respiratory Devices Market Variables, Trends & Scope
3.1. Market Dynamics
3.1.1. Market driver analysis
3.1.1.1. Rise in Chronic Respiratory Diseases and Geriatric Population
3.1.1.2. Technological Advancements
3.1.1.3. Supportive Initiatives by Government and Private Organizations
3.1.2. Market Restraint analysis
3.1.2.1. Product Recalls & Failure
3.1.2.2. Complexity of Modern Anesthesia and Respiratory Machines
3.1.3. Market Opportunities
3.2. Anesthesia and Respiratory Devices Market Analysis Tools
3.2.1. Industry Analysis - Porter’s
3.2.1.1. Supplier power
3.2.1.2. Buyer power
3.2.1.3. Substitution threat
3.2.1.4. Threat of new entrant
3.2.1.5. Competitive rivalry
3.2.2. PESTEL Analysis
3.2.2.1. Political landscape
3.2.2.2. Economic landscape
3.2.2.3. Social landscape
3.2.2.4. Technological landscape
3.2.2.5. Environmental landscape
3.2.2.6. Legal landscape
Chapter 4. Anesthesia and Respiratory Devices Market: Product Estimates & Trend Analysis
4.1. Product Type Market Share, 2024 & 2033
4.2. Segment Dashboard
4.3. Global Brain Computer Interface Market by Product Type Outlook
4.3.1. Anesthesia Devices
4.3.1.1. Anesthesia Devices market estimates and forecasts, 2021-2033 (USD Million)
4.3.1.1.1. Anesthesia Machines
4.3.1.1.1.1. Anesthesia Machines market estimates and forecasts, 2021-2033 (USD Million)
4.3.1.1.1.2. Anesthesia Workstation
4.3.1.1.1.2.1. Anesthesia Workstation market estimates and forecasts, 2021-2033 (USD Million)
4.3.1.1.1.3. Anesthesia Delivery Machines
4.3.1.1.1.3.1. Anesthesia Delivery Station market estimates and forecasts, 2021-2033 (USD Million)
4.3.1.1.1.3.2. Portable Anesthesia Delivery Machine
4.3.1.1.1.3.2.1. Portable Anesthesia Delivery Machine market estimates and forecasts, 2021-2033 (USD Million)
4.3.1.1.1.3.3. Standalone Anesthesia Delivery Machine
4.3.1.1.1.3.3.1. Standalone Anesthesia Delivery Machine market estimates and forecasts, 2021-2033 (USD Million)
4.3.1.1.1.4. Anesthesia Ventilators
4.3.1.1.1.4.1. Anesthesia Ventilators market estimates and forecasts, 2021-2033 (USD Million)
4.3.1.1.1.5. Anesthesia Monitors
4.3.1.1.1.5.1. Anesthesia Monitors market estimates and forecasts, 2021-2033 (USD Million)
4.3.1.1.2. Anesthesia Disposables
4.3.1.1.2.1. Anesthesia Disposables market estimates and forecasts, 2021-2033 (USD Million)
4.3.1.1.2.2. Anesthesia Masks
4.3.1.1.2.2.1. Anesthesia Masks market estimates and forecasts, 2021-2033 (USD Million)
4.3.1.1.2.3. Anesthesia Accessories
4.3.1.1.2.3.1. Anesthesia Accessories market estimates and forecasts, 2021-2033 (USD Million)
4.3.2. Respiratory Devices
4.3.2.1. Respiratory devices market estimates and forecasts, 2021-2033 (USD Million)
4.3.2.1.1. Respiratory Equipment
4.3.2.1.1.1. Respiratory Equipment’s market estimates and forecasts, 2021-2033 (USD Million)
4.3.2.1.1.2. Humidifiers
4.3.2.1.1.2.1. Humidifiers market estimates and forecasts, 2021-2033 (USD Million)
4.3.2.1.1.2.2. Heat Humidifiers
4.3.2.1.1.2.2.1. Heat Humidifiers market estimates and forecasts, 2021-2033 (USD Million)
4.3.2.1.1.2.3. Heated wire breathing circuits
4.3.2.1.1.2.3.1. Heated wire breathing circuits market estimates and forecasts, 2021-2033 (USD Million)
4.3.2.1.1.2.4. Heat Exchangers
4.3.2.1.1.2.4.1. Heat Exchangers market estimates and forecasts, 2021-2033 (USD Million)
4.3.2.1.1.2.5. Pass Over Humidifiers
4.3.2.1.1.2.5.1. Pass Over Humidifiers market estimates and forecasts, 2021-2033 (USD Million)
4.3.2.1.1.3. Nebulizers
4.3.2.1.1.3.1. Nebulizers market estimates and forecasts, 2021-2033 (USD Million)
4.3.2.1.1.3.2. Pneumatic nebulizers
4.3.2.1.1.3.2.1. Pneumatic nebulizers market estimates and forecasts, 2021-2033 (USD Million)
4.3.2.1.1.3.3. Mesh nebulizers
4.3.2.1.1.3.3.1. Mesh nebulizers market estimates and forecasts, 2021-2033 (USD Million)
4.3.2.1.1.3.4. Ultrasonic nebulizers
4.3.2.1.1.3.4.1. Ultrasonic nebulizers market estimates and forecasts, 2021-2033 (USD Million)
4.3.2.1.1.4. Oxygen Concentrators
4.3.2.1.1.4.1. Oxygen Concentrators market estimates and forecasts, 2021-2033 (USD Million)
4.3.2.1.1.4.2. Fixed Oxygen Concentrators
4.3.2.1.1.4.2.1. Fixed Oxygen Concentrators market estimates and forecasts, 2021-2033 (USD Million)
4.3.2.1.1.4.3. Portable Oxygen Concentrators
4.3.2.1.1.4.3.1. Portable Oxygen Concentrators market estimates and forecasts, 2021-2033 (USD Million)
4.3.2.1.1.5. Positive airway pressure devices
4.3.2.1.1.5.1. Positive airway pressure devices market estimates and forecasts, 2021-2033 (USD Million)
4.3.2.1.1.5.2. Bi-level positive airway pressure devices
4.3.2.1.1.5.2.1. Bi-level positive airway pressure devices market estimates and forecasts, 2021-2033 (USD Million)
4.3.2.1.1.5.3. Continuous positive airway pressure devices
4.3.2.1.1.5.3.1. Continuous positive airway pressure devices market estimates and forecasts, 2021-2033 (USD Million)
4.3.2.1.1.6. Reusable resuscitators
4.3.2.1.1.6.1. Reusable resuscitators market estimates and forecasts, 2021-2033 (USD Million)
4.3.2.1.1.7. Ventilators
4.3.2.1.1.7.1. Ventilators market estimates and forecasts, 2021-2033 (USD Million)
4.3.2.1.1.7.2. Adult Ventilators
4.3.2.1.1.7.2.1. Adult Ventilators market estimates and forecasts, 2021-2033 (USD Million)
4.3.2.1.1.7.3. Neonatal Ventilators
4.3.2.1.1.7.3.1. Neonatal Ventilators market estimates and forecasts, 2021-2033 (USD Million)
4.3.2.1.1.8. Respiratory inhalers
4.3.2.1.1.8.1. Respiratory inhalers market estimates and forecasts, 2021-2033 (USD Million)
4.3.2.1.1.8.2. Dry Powdered Inhalers
4.3.2.1.1.8.2.1. Dry Powdered Inhalers market estimates and forecasts, 2021-2033 (USD Million)
4.3.2.1.1.8.3. Metered Dose Inhalers
4.3.2.1.1.8.3.1. Metered Dose Inhalers market estimates and forecasts, 2021-2033 (USD Million)
4.3.2.1.1.9. Respiratory disposable
4.3.2.1.1.9.1. Respiratory disposable market estimates and forecasts, 2021-2033 (USD Million)
4.3.2.1.1.9.2. Disposable Oxygen Mask
4.3.2.1.1.9.2.1. Disposable oxygen mask market estimates and forecasts, 2021-2033 (USD Million)
4.3.2.1.1.9.3. Resuscitators
4.3.2.1.1.9.3.1. Resuscitators market estimates and forecasts, 2021-2033 (USD Million)
4.3.2.1.1.9.4. Tracheostomy Tubes
4.3.2.1.1.9.4.1. Tracheostomy Tubes market estimates and forecasts, 2021-2033 (USD Million)
4.3.2.1.1.9.5. Oxygen Cannula
4.3.2.1.1.9.5.1. Oxygen Cannula market estimates and forecasts, 2021-2033 (USD Million)
4.3.2.1.1.10. Respiratory measurement devices
4.3.2.1.1.10.1. Respiratory measurement devices market estimates and forecasts, 2021-2033 (USD Million)
4.3.2.1.1.10.2. Pulse oximetry systems
4.3.2.1.1.10.2.1. Pulse oximetry systems market estimates and forecasts, 2021-2033 (USD Million)
4.3.2.1.1.10.3. Capnographs
4.3.2.1.1.10.3.1. Capnographs market estimates and forecasts, 2021-2033 (USD Million)
4.3.2.1.1.10.4. Spirometers
4.3.2.1.1.10.4.1. Spirometers market estimates and forecasts, 2021-2033 (USD Million)
4.3.2.1.1.10.5. Peak flowmeters
4.3.2.1.1.10.5.1. Peak flowmeters market estimates and forecasts, 2021-2033 (USD Million)
Chapter 5. Anesthesia and Respiratory Devices Market: Regional Estimates & Trend Analysis, by Product
5.1. Regional Market Share Analysis, 2024 & 2033
5.2. Regional Market Dashboard
5.3. Global Regional Market Snapshot
5.4. North America
5.4.1. U.S.
5.4.1.1. Key country dynamics
5.4.1.2. Regulatory framework/ reimbursement structure
5.4.1.3. Competitive scenario
5.4.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
5.4.2. Canada
5.4.2.1. Key country dynamics
5.4.2.2. Regulatory framework/ reimbursement structure
5.4.2.3. Competitive scenario
5.4.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
5.4.3. Mexico
5.4.3.1. Key country dynamics
5.4.3.2. Regulatory framework/ reimbursement structure
5.4.3.3. Competitive scenario
5.4.3.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
5.5. Europe
5.5.1. UK
5.5.1.1. Key country dynamics
5.5.1.2. Regulatory framework/ reimbursement structure
5.5.1.3. Competitive scenario
5.5.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
5.5.2. Germany
5.5.2.1. Key country dynamics
5.5.2.2. Regulatory framework/ reimbursement structure
5.5.2.3. Competitive scenario
5.5.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
5.5.3. France
5.5.3.1. Key country dynamics
5.5.3.2. Regulatory framework/ reimbursement structure
5.5.3.3. Competitive scenario
5.5.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
5.5.4. Italy
5.5.4.1. Key country dynamics
5.5.4.2. Regulatory framework/ reimbursement structure
5.5.4.3. Competitive scenario
5.5.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
5.5.5. Spain
5.5.5.1. Key country dynamics
5.5.5.2. Regulatory framework/ reimbursement structure
5.5.5.3. Competitive scenario
5.5.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
5.5.6. Norway
5.5.6.1. Key country dynamics
5.5.6.2. Regulatory framework/ reimbursement structure
5.5.6.3. Competitive scenario
5.5.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
5.5.7. Sweden
5.5.7.1. Key country dynamics
5.5.7.2. Regulatory framework/ reimbursement structure
5.5.7.3. Competitive scenario
5.5.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
5.5.8. Denmark
5.5.8.1. Key country dynamics
5.5.8.2. Regulatory framework/ reimbursement structure
5.5.8.3. Competitive scenario
5.5.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
5.6. Asia Pacific
5.6.1. Japan
5.6.1.1. Key country dynamics
5.6.1.2. Regulatory framework/ reimbursement structure
5.6.1.3. Competitive scenario
5.6.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
5.6.2. China
5.6.2.1. Key country dynamics
5.6.2.2. Regulatory framework/ reimbursement structure
5.6.2.3. Competitive scenario
5.6.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
5.6.3. India
5.6.3.1. Key country dynamics
5.6.3.2. Regulatory framework/ reimbursement structure
5.6.3.3. Competitive scenario
5.6.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
5.6.4. Australia
5.6.4.1. Key country dynamics
5.6.4.2. Regulatory framework/ reimbursement structure
5.6.4.3. Competitive scenario
5.6.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
5.6.5. South Korea
5.6.5.1. Key country dynamics
5.6.5.2. Regulatory framework/ reimbursement structure
5.6.5.3. Competitive scenario
5.6.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
5.6.6. Thailand
5.6.6.1. Key country dynamics
5.6.6.2. Regulatory framework/ reimbursement structure
5.6.6.3. Competitive scenario
5.6.6.4. Singapore market estimates and forecasts 2021 to 2033 (USD Million)
5.7. Latin America
5.7.1. Brazil
5.7.1.1. Key country dynamics
5.7.1.2. Regulatory framework/ reimbursement structure
5.7.1.3. Competitive scenario
5.7.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
5.7.2. Argentina
5.7.2.1. Key country dynamics
5.7.2.2. Regulatory framework/ reimbursement structure
5.7.2.3. Competitive scenario
5.7.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
5.8. MEA
5.8.1. South Africa
5.8.1.1. Key country dynamics
5.8.1.2. Regulatory framework/ reimbursement structure
5.8.1.3. Competitive scenario
5.8.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
5.8.2. Saudi Arabia
5.8.2.1. Key country dynamics
5.8.2.2. Regulatory framework/ reimbursement structure
5.8.2.3. Competitive scenario
5.8.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
5.8.3. UAE
5.8.3.1. Key country dynamics
5.8.3.2. Regulatory framework/ reimbursement structure
5.8.3.3. Competitive scenario
5.8.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
5.8.4. Kuwait
5.8.4.1. Key country dynamics
5.8.4.2. Regulatory framework/ reimbursement structure
5.8.4.3. Competitive scenario
5.8.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 6. Competitive Landscape
6.1. Recent Developments & Impact Analysis, by Key Market Participants
6.2. Company/Competition Categorization
6.3. Key company market share/position analysis, 2024
6.4. Company Profiles
6.4.1. Medtronic
6.4.1.1. Company Overview
6.4.1.2. Financial Performance
6.4.1.3. Product Benchmarking
6.4.1.4. Strategic initiatives
6.4.2. Teleflex Incorporated
6.4.2.1. Company Overview
6.4.2.2. Financial Performance
6.4.2.3. Product Benchmarking
6.4.2.4. Strategic initiatives
6.4.3. Koninklijke Philips N.V.
6.4.3.1. Company Overview
6.4.3.2. Financial Performance
6.4.3.3. Product Benchmarking
6.4.3.4. Strategic initiatives
6.4.4. Drägerwerk AG & Co. KGaA
6.4.4.1. Company Overview
6.4.4.2. Financial Performance
6.4.4.3. Product Benchmarking
6.4.4.4. Strategic initiatives
6.4.5. Getinge AB.
6.4.5.1. Company Overview
6.4.5.2. Financial Performance
6.4.5.3. Product Benchmarking
6.4.5.4. Strategic initiatives
6.4.6. Smiths Group plc
6.4.6.1. Company Overview
6.4.6.2. Financial Performance
6.4.6.3. Product Benchmarking
6.4.6.4. Strategic initiatives
6.4.7. Fisher & Paykel Healthcare Limited.
6.4.7.1. Company Overview
6.4.7.2. Financial Performance
6.4.7.3. Product Benchmarking
6.4.7.4. Strategic initiatives
6.4.8. Masimo
6.4.8.1. Company Overview
6.4.8.2. Financial Performance
6.4.8.3. Product Benchmarking
6.4.8.4. Strategic initiatives
6.4.9. B. Braun Melsungen AG
6.4.9.1. Company Overview
6.4.9.2. Financial Performance
6.4.9.3. Product Benchmarking
6.4.9.4. Strategic initiatives
6.4.10. ResMed
6.4.10.1. Company Overview
6.4.10.2. Financial Performance
6.4.10.3. Product Benchmarking
6.4.10.4. Strategic initiatives
6.4.11. Shenzhen Mindray Bio-Medical Electronics Co., Ltd
6.4.11.1. Company Overview
6.4.11.2. Financial Performance
6.4.11.3. Product Benchmarking
6.4.11.4. Strategic initiatives
6.4.12. Inogen, Inc.
6.4.12.1. Company Overview
6.4.12.2. Financial Performance
6.4.12.3. Product Benchmarking
6.4.12.4. Strategic initiatives
6.4.13. Caire Medical (a subsidiary of NGK Spark Plug)
6.4.13.1. Company Overview
6.4.13.2. Financial Performance
6.4.13.3. Product Benchmarking
6.4.13.4. Strategic initiatives
6.4.14. DeVilbiss Healthcare (a subsidiary of Drive Medical).
6.4.14.1. Company Overview
6.4.14.2. Financial Performance
6.4.14.3. Product Benchmarking
6.4.14.4. Strategic initiatives
6.4.15. React Health (Respiratory Product Line from Invacare Corporation)
6.4.15.1. Company Overview
6.4.15.2. Financial Performance
6.4.15.3. Product Benchmarking
6.4.15.4. Strategic initiatives
6.4.16. O2 Concepts
6.4.16.1. Company Overview
6.4.16.2. Financial Performance
6.4.16.3. Product Benchmarking
6.4.16.4. Strategic initiatives
6.4.17. Nidek Medical Products, Inc.
6.4.17.1. Company Overview
6.4.17.2. Financial Performance
6.4.17.3. Product Benchmarking
6.4.17.4. Strategic initiatives
6.4.18. Omron Corporation
6.4.18.1. Company Overview
6.4.18.2. Financial Performance
6.4.18.3. Product Benchmarking
6.4.18.4. Strategic initiatives
6.4.19. GE Healthcare
6.4.19.1. Company Overview
6.4.19.2. Financial Performance
6.4.19.3. Product Benchmarking
6.4.19.4. Strategic initiatives
6.4.20. Allied Healthcare
6.4.20.1. Company Overview
6.4.20.2. Financial Performance
6.4.20.3. Product Benchmarking
6.4.20.4. Strategic initiatives
6.4.21. Vectura Group Plc.
6.4.21.1. Company Overview
6.4.21.2. Financial Performance
6.4.21.3. Product Benchmarking
6.4.21.4. Strategic initiatives
6.4.22. PARI Respiratory Equipment, Inc.
6.4.22.1. Company Overview
6.4.22.2. Financial Performance
6.4.22.3. Product Benchmarking
6.4.22.4. Strategic initiatives
6.4.23. Aerogen
6.4.23.1. Company Overview
6.4.23.2. Financial Performance
6.4.23.3. Product Benchmarking
6.4.23.4. Strategic initiatives
6.4.24. Beurer
6.4.24.1. Company Overview
6.4.24.2. Financial Performance
6.4.24.3. Product Benchmarking
6.4.24.4. Strategic initiatives
6.4.25. Briggs Healthcare
6.4.25.1. Company Overview
6.4.25.2. Financial Performance
6.4.25.3. Product Benchmarking
6.4.25.4. Strategic initiatives
List of Tables
Table 1 North America Anesthesia & Respiratory Devices Market, by Region, 2021-2033 (USD Million)
Table 2 North America Anesthesia and Respiratory Devices Market, by Product, 2021-2033 (USD Million)
Table 3 U.S Anesthesia and Respiratory Devices Market, by Product, 2021-2033 (USD Million)
Table 4 Canada Anesthesia and Respiratory Devices Market, by Product, 2021-2033 (USD Million)
Table 5 Mexico Anesthesia and Respiratory Devices Market, by Product, 2021-2033 (USD Million)
Table 6 Europe Anesthesia and Respiratory Devices Market, by Region, 2021-2033 (USD Million)
Table 7 Europe Anesthesia and Respiratory Devices Market, by Product, 2021-2033 (USD Million)
Table 8 UK Anesthesia and Respiratory Devices Market, by Product, 2021-2033 (USD Million)
Table 9 Germany Anesthesia and Respiratory Devices Market, by Product, 2021-2033 (USD Million)
Table 10 France Anesthesia and Respiratory Devices Market, by Product, 2021-2033 (USD Million)
Table 11 Italy Anesthesia and Respiratory Devices Market, by Product, 2021-2033 (USD Million)
Table 12 Spain Anesthesia and Respiratory Devices Market, by Product, 2021-2033 (USD Million)
Table 13 Sweden Anesthesia and Respiratory Devices Market, by Product, 2021-2033 (USD Million)
Table 14 Denmark Anesthesia and Respiratory Devices Market, by Product, 2021-2033 (USD Million)
Table 15 Norway Anesthesia and Respiratory Devices Market, by Product, 2021-2033 (USD Million)
Table 16 Asia-Pacific Anesthesia and Respiratory Devices Market, by Region, 2021-2033 (USD Million)
Table 17 Asia-Pacific Anesthesia and Respiratory Devices Market, by Region, 2021-2033 (USD Million)
Table 18 China Anesthesia and Respiratory Devices Market, by Product, 2021-2033 (USD Million)
Table 19 Japan Anesthesia and Respiratory Devices Market, by Product, 2021-2033 (USD Million)
Table 20 India Anesthesia and Respiratory Devices Market, by Product, 2021-2033 (USD Million)
Table 21 Australia Anesthesia and Respiratory Devices Market, by Product, 2021-2033 (USD Million)
Table 22 South Korea Anesthesia and Respiratory Devices Market, by Product, 2021-2033 (USD Million)
Table 23 Thailand Anesthesia and Respiratory Devices Market, by Product, 2021-2033 (USD Million)
Table 24 Latin America Anesthesia and Respiratory Devices Market, by Region, 2021-2033 (USD Million)
Table 25 Latin America Anesthesia and Respiratory Devices Market, by Product, 2021-2033 (USD Million)
Table 26 Brazil Anesthesia and Respiratory Devices Market, by Product, 2021-2033 (USD Million)
Table 27 Argentina Anesthesia and Respiratory Devices Market, by Product, 2021-2033 (USD Million)
Table 28 MEA Anesthesia and Respiratory Devices Market, by Region, 2021-2033 (USD Million)
Table 29 MEA Anesthesia and Respiratory Devices Market, by Product, 2021-2033 (USD Million)
Table 30 South Africa Anesthesia and Respiratory Devices Market, by Product, 2021-2033 (USD Million)
Table 31 Saudi Arabia Anesthesia and Respiratory Devices Market, by Product, 2021-2033 (USD Million)
Table 32 UAE Anesthesia and Respiratory Devices Market, by Product, 2021-2033 (USD Million)
Table 33 Kuwait Anesthesia and Respiratory Devices Market, by Product, 2021-2033 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Data triangulation techniques
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 Value-chain-based sizing & forecasting
Figure 6 QFD modeling for market share assessment
Figure 7 Market formulation & validation
Figure 8 Aesthesia and respiratory devices market outlook
Figure 9 Aesthesia and respiratory devices competitive insights
Figure 10 Parent market outlook
Figure 11 Related/ancillary market outlook
Figure 12 Penetration and growth prospect mapping
Figure 13 Industry value chain analysis
Figure 14 Aesthesia and respiratory devices market driver impact
Figure 15 Aesthesia and respiratory devices market restraint impact
Figure 16 Aesthesia and respiratory devices market strategic initiatives analysis
Figure 17 Aesthesia and respiratory devices market: Product movement analysis
Figure 18 Aesthesia and respiratory devices market: Product outlook and key takeaways
Figure 19 Anesthesia devices market, 2021-2033 (USD Million)
Figure 20 Anesthesia delivery machines market, 2021-2033 (USD Million)
Figure 21 Anesthesia monitors market, 2021-2033 (USD Million)
Figure 22 Anesthesia ventilators market, 2021-2033 (USD Million)
Figure 23 Anesthesia workstations market, 2021-2033 (USD Million)
Figure 24 Anesthesia disposables market, 2021-2033 (USD Million)
Figure 25 Anesthesia disposables masks market, 2021-2033 (USD Million)
Figure 26 Anesthesia disposable accessories market, 2021-2033 (USD Million)
Figure 27 Respiratory devices market, 2021-2033 (USD Million)
Figure 28 Positive airway pressure market, 2021-2033 (USD Million)
Figure 29 Ventilators market, 2021-2033 (USD Million)
Figure 30 Nebulizers market, 2021-2033 (USD Million)
Figure 31 Humidifiers market, 2021-2033 (USD Million)
Figure 32 Respiratory inhalers market, 2021-2033 (USD Million)
Figure 33 Oxygen concentrators market, 2021-2033 (USD Million)
Figure 34 Reusable resuscitators market, 2021-2033 (USD Million)
Figure 35 Pulse oximeters market, 2021-2033 (USD Million)Anesthesia Devices
Figure 36 Capnographs market, 2021-2033 (USD Million)
Figure 37 Spirometers market, 2021-2033 (USD Million)
Figure 38 Peak flow meters market, 2021-2033 (USD Million)
Figure 39 Global aesthesia and respiratory devices market: Regional movement analysis
Figure 40 Global aesthesia and respiratory devices market: Regional outlook and key takeaways
Figure 41 Global anesthesia and respiratory devices market share and leading players
Figure 42 North America market share and leading players
Figure 43 Europe market share and leading players
Figure 44 Asia-Pacific market share and leading players
Figure 45 Latin America market share and leading players
Figure 46 Middle East & Africa market share and leading players
Figure 47 North America: SWOT
Figure 48 Europe SWOT
Figure 49 Asia-Pacific SWOT
Figure 50 Latin America SWOT
Figure 51 MEA SWOT
Figure 52 North America market estimates and forecasts, 2021-2033 (USD Million)
Figure 53 U.S. market estimates and forecasts, 2021-2033 (USD Million)
Figure 54 Canada market estimates and forecasts, 2021-2033 (USD Million)
Figure 55 Mexico market estimates and forecasts, 2021-2033 (USD Million)
Figure 56 Europe market estimates and forecasts, 2021-2033 (USD Million)
Figure 57 UK market estimates and forecasts, 2021-2033 (USD Million)
Figure 58 Germany market estimates and forecasts, 2021-2033 (USD Million)
Figure 59 France market estimates and forecasts, 2021-2033 (USD Million)
Figure 60 Italy market estimates and forecasts, 2021-2033 (USD Million)
Figure 61 Spain market estimates and forecasts, 2021-2033 (USD Million)
Figure 62 Denmark market estimates and forecasts, 2021-2033 (USD Million)
Figure 63 Sweden market estimates and forecasts, 2021-2033 (USD Million)
Figure 64 Norway market estimates and forecasts, 2021-2033 (USD Million)
Figure 65 Asia-Pacific market estimates and forecasts, 2021-2033 (USD Million)
Figure 66 China market estimates and forecasts, 2021-2033 (USD Million)
Figure 67 Japan market estimates and forecasts, 2021-2033 (USD Million)
Figure 68 India market estimates and forecasts, 2021-2033 (USD Million)
Figure 69 Thailand market estimates and forecasts, 2021-2033 (USD Million)
Figure 70 South Korea market estimates and forecasts, 2021-2033 (USD Million)
Figure 71 Australia market estimates and forecasts, 2021-2033 (USD Million)
Figure 72 Latin America market estimates and forecasts, 2021-2033 (USD Million)
Figure 73 Brazil market estimates and forecasts, 2021-2033 (USD Million)
Figure 74 Argentina market estimates and forecasts, 2021-2033 (USD Million)
Figure 75 Middle East and Africa market estimates and forecasts, 2021-2033 (USD Million)
Figure 76 South Africa market estimates and forecasts, 2021-2033 (USD Million)
Figure 77 Saudi Arabia market estimates and forecasts, 2021-2033 (USD Million)
Figure 78 UAE market estimates and forecasts, 2021-2033 (USD Million)
Figure 79 Kuwait market estimates and forecasts, 2021-2033 (USD Million)
Figure 80 Market share of key market players- aesthesia and respiratory devices market
Figure 81 Key Company Categorization
Figure 82 Company Market Share/Position Analysis, 2024
Figure 83 Strategic Framework

Companies Mentioned

The companies profiled in this Anesthesia and Respiratory Devices market report include:
  • Medtronic
  • Teleflex Incorporated
  • Koninklijke Philips N.V.
  • Drägerwerk AG & Co. KGaA
  • Getinge AB.
  • Smiths Group plc
  • Fisher & Paykel Healthcare Limited.
  • Masimo
  • B. Braun Melsungen AG
  • ResMed
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd
  • Inogen, Inc.
  • Caire Medical (a subsidiary of NGK Spark Plug),
  • DeVilbiss Healthcare (a subsidiary of Drive Medical).
  • React Health (Respiratory Product Line from Invacare Corporation)
  • O2 Concepts
  • Nidek Medical Products, Inc.
  • Omron Corporation
  • GE Healthcare
  • Allied Healthcare
  • Vectura Group Plc.
  • PARI Respiratory Equipment, Inc.
  • Aerogen
  • Briggs Healthcare
  • Beurer GmBH

Table Information

Report AttributeDetails
No. of Pages250
PublishedOctober 2025
Forecast Period2024 - 2033
Estimated Market Value ( USD ) in 2024 $ 56.3 Billion
Forecasted Market Value ( USD ) by 2033 $ 91.5 Billion
Compound Annual Growth Rate5.6%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Middle East Anesthesia and Respiratory Devices Market Size, Share & Trends Analysis Report by Product (Respiratory Devices, Anesthesia Devices (Machines, Disposables)), and Country with Growth Forecasts, 2025-2033 - Product Image

Middle East Anesthesia and Respiratory Devices Market Size, Share & Trends Analysis Report by Product (Respiratory Devices, Anesthesia Devices (Machines, Disposables)), and Country with Growth Forecasts, 2025-2033

  • Report
  • 90 Pages
  • Middle East
From
Anesthesia and Respiratory Devices Market Report by Product Type, End User, Region 2025-2033 - Product Image

Anesthesia and Respiratory Devices Market Report by Product Type, End User, Region 2025-2033

  • Report
  • 142 Pages
  • Global
From
Australia Anesthesia and Respiratory Devices Market Outlook to 2033 - Anesthesia Devices, Airway Management and Respiratory Devices - Product Image

Australia Anesthesia and Respiratory Devices Market Outlook to 2033 - Anesthesia Devices, Airway Management and Respiratory Devices

  • Report
  • 122 Pages
  • Australia
From
Brazil Anesthesia and Respiratory Devices Market Outlook to 2033 - Anesthesia Devices, Airway Management and Respiratory Devices - Product Image

Brazil Anesthesia and Respiratory Devices Market Outlook to 2033 - Anesthesia Devices, Airway Management and Respiratory Devices

  • Report
  • 118 Pages
  • Brazil
From
Spain Anesthesia and Respiratory Devices Market Outlook to 2033 - Anesthesia Devices, Airway Management and Respiratory Devices - Product Image

Spain Anesthesia and Respiratory Devices Market Outlook to 2033 - Anesthesia Devices, Airway Management and Respiratory Devices

  • Report
  • 115 Pages
  • Spain
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.